期刊文献+

烟碱乙酰胆碱受体显像剂2-[^(18)F]-A-85380的合成及小鼠体内分布 被引量:4

Radiosynthesis of 2-[^(18)F]-A-85380 and Its Biodistribution in Mice
在线阅读 下载PDF
导出
摘要 目的探讨2-[18F]-A-85380的合成及在小鼠体内分布。方法以Me3N+-Boc-A-85380、CF3S03-为反应前体,在含氮芳香环的2位用18F进行标记,合成nAChRs显像剂2[-18F]-A-85380;以聚酰胺薄膜为支持介质、生理盐水为展开剂,测定标记物的标记率和放化纯度;KM小鼠尾静脉注射0.5 mL(1.295 MBq)2[-18F]-A-85380,分别在5、15、30、60、90、120、150、180 min处死。取血、心、肝、脾、肺、肾、胃、小肠、膀胱、甲状腺、颌下腺、脑、肌肉、大肠、骨骼,测其质量及放射性计数,计算%ID/g。结果2[-18F]-A-85380的标记率达93%,其放化纯在标记后2、4、6 h均大于90%。药物分布结果显示,2[-18F]-A-85380在小鼠体内广泛分布,主要经过肝脏和肾脏进行代谢。肝、肾的放射性摄取在注入后5 min时分别为0.289%ID/g、0.590%ID/g,180 min时则分别下降为0.024%ID/g、0.016%ID/g,血液中放射性清除较快,注入后5 min时血液中放射性摄取为0.093%ID/g,180 min时为0.002%ID/g。注入后60 min脑中的放射性摄取达到最高值为0.145%ID/g,150 min时脑内摄取大于其他组织器官,脑中摄取较多、清除缓慢、状态稳定,脑中分布达稳定状态的时间大于180 min。胃和颌下腺中摄取也较多,膀胱辐射吸收剂量最高。结论2[-18F]-A-85380制备方便,体外稳定,体内主要经过肝、肾代谢,脑内分布较多且状态稳定,可用于进一步的烟碱受体显像研究。 Objective To investigate the radiosynthesis of 2-[18F]-A-85380 and its biodistribution in mice.Methods 2-[18F]-A-85380 was synthesized with Me3N +-Boc-A-85380.CF3S03-as precursor,using 18F labeled the nitrogen-containing aromatic ring.The radiolabeled compound was characterized by polymide TLC,in which the substratum of saline was used as developing agent to measure the radiochemical purity and labeling yield.KM mice were sacrificed at 5,15,30 60,90,120 150,180 min after tail vein injection of 0.5 mL(1.295MBq)freshly prepared 2-[18E]-A-85380.Samples of blood,heart,hver,spleen,lung,kidney,stomach,small intestine,bladder,thyroid,submandibular gland,brain,muscle,large intestine and bone were taken,weighed and gamma counts were measured.The percent of injected dose per gram (%ID/g) was calculated for each sample.Results The labeling yield of 2-[18F]-A-85380 was 93% and its radiochemical purity exceeded 90% at 2,4 and 6 h.Biodistribution in mice demonstrated that 2-[18F]-A-85380 was extensive in mice,and it was metabolized mainly in liver and kidney,as indicated by their uptake of 0.289% ID/g and 0.590% ID/g at 5 min dropping to 0.024% ID/g and 0.016% ID/g at 180 min,respectively.The brain uptake of 2-[18F]-A-85380 in mice reached a maximum of 0.145% ID/g at 60 min after injection.And the uptake of brain exceeded the other organs at 150 min after injection,with the most uptake,the slowest elimination and stable state.The stability of brain distribution needed more than 180 min.The distribution of stomach and submandibular gland were relative high as well.Bladder wall received the highest radiation dose.Conclusion The preparation of 2-[18F]-A-85380 is convenient and stable and it is metabolized mainly in liver and kidney and exhibits a relative high uptake and stable state in brain,which is worthy of further studying for nAChRs imaging.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2013年第9期777-780,共4页 Journal of China Medical University
基金 国家自然科学基金(81000623)
关键词 2-[18F]-A-85380 烟碱乙酰胆碱受体 小鼠 2-[18F]-A-85380 nAChRs mice
  • 相关文献

参考文献7

  • 1Kadir A, Ahnkvist O, Wall A,et al. PET imaging of cortical UC-nico- tine binding correlates with the cognitive function of attention in Alzheimer' s disease [ J ]. Psychopharmacology, 2006,188 (4) : 509 - 520.
  • 2Esterlis I, Hannestad JO, Perkins E, et al. Effect of a nicotine vaccine on nicotine binding to 132-nicotinic acetylcholine receptors in vivo in human tobacco smokers [ J ]. Am J Psychiatry, 2013,170 (4) : 399- 407.
  • 3Lotfipour S, Mandelkern M, Brody AL. Quantitative molecular imag- ing of neuronal nicotinic acetylcholine receptors in the human brain with A-85380 radiotracers [ J ]. Curr Med Imaging Rev, 201 1, 7 ( 2 ) : 107-112.
  • 4张赟,吴战宏,李方,朱立,Dollé F,Kühnast B.2-^(18)F-A-85380的制备与MicroPET显像[J].同位素,2008,21(1):15-19. 被引量:5
  • 5Schildan A, Patt M, Sabri O. Synthesis procedure for routine produc- tion of 2- [ 'SF ] fluoro-3 - ( 2 ( S ) -azetidinylmethoxy )pyridine ( 2- [ IsF- F- A-85380) [J]. Appl Radiat Isot, 2007,65( 11 ) : 1244-1248.
  • 6Gallezot JD, Bottlaender MA, Delforge J, et al.Quantifieation of eere- bral nicotinic aeetyleholine receptors by PET using 2-[ -SF]-A-85380 and the multiinjection approach [J]. J Cereb Blood Flow Metab, 2008,28( 1 ) : 172-189.
  • 7Ellis JR, Nathan PJ, Villemagne VL, et ah The relationship between nicotinic receptors and cognitive functioning in healthy aging:An in vivo positron emission tomography (PET) study with 2-[ ISF ]fluoro- A-85380 [J]. Synapse,2009,63(9):752-763.

二级参考文献11

  • 1DANI JA. Overview of Nicotinic Receptors and Their Roles in the Central Nervous System [J]. Biol Psychiatry, 2001, 49 : 166-174.
  • 2SIHVER W, LANGSTROM B, NORDBERG A. Ligands for in Vivo Imaging of Nicotinic Receptor Subtypes in Alzheimer Brain [J]. Acta Neurol Scand, 2000, 176 (Suppl):27-33.
  • 3PATERSON D, NORDBERG A. Nicotinic Acetylcholine Receptor and Imaging [J]. Prog Neurobiol, 2000, 61:75-111.
  • 4VALETTE H, BOTTLAENDER M, DOLLE F, et al. An Attempt to Visualize Brain Nicotinic Receptors With ^11C-ABT-418 and N-^11 C-methyl Cytisine[J]. Nucl Med Commun, 1997, 18:164-168.
  • 5ROGER G, LAGNEL B, ROUDEN J. Synthesis of a 2-pyridiny1-^18 F-labeled Fluoro Derivative of (-)-cytisine as a Candidate Radioligand for Brain Nicotinic α4β2 Receptor Imaging With PET[J]. Bioorg Med Chem, 2003,11:5 333-5 343.
  • 6HOLLADAY MW, DART MJ, LYNCH JK. Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery[J]. J Med Chem, 1997, 40 (26):4 169-4 194.
  • 7BOTTLAENDER M, VALETTE H, ROUMENOV D, et al. Biodistribution and Radiation Dosimetry of ^18F-fluoro-A-85380 in Healthy Volunteers [J]. J Nucl Med, 2003, 44 (4):596-601.
  • 8DOLLE F, VALETTE H, BOTTLAENDER M, et al. Synthesis of 2-[^18F] Fluoro-3-[2(S)- azetidinylmethoxy] Pyridine, a Highly Potent Radioligand for in Vivo Imaging Central Nicotinic Acetylcholine Receptors [J]. J Labeled Compd Radiopharm, 1998, 41:451-463.
  • 9DOLLE F, DOLCI L, VALETTE H, et al. Synthesis and Nicotinic Acetylcholine Receptor in Vivo Binding Properties of 2-Fluoro-3-[2(S)-azetidinylmethoxy] pyridine: a New Positron Emission Tomography Ligand for Nicotinic Receptors[J]. J Med Chem, 1999, 42:2 251-2 259.
  • 10MITKOVSKI S, VILLEMAGNE VL, NOVAKOVIC KE, et al. Simplified Quantification of Nicotinic Receptors With 2[^18F] F-A-85380 PET[J]. Nucl Med Biol, 2005, 32(6):585-591.

共引文献4

同被引文献75

  • 1李华,刘春萍,张华北.神经型烟碱乙酰胆碱α4β2受体显像剂研究进展[J].中华核医学杂志,2005,25(3):184-187. 被引量:8
  • 2Kendziorra K, Wolf creased cerebral α4β2 availability in patient H, Meyer P M, et nicotinic acetylcholine s with mild cognitive receptor merit and Alzheimer' s disease assessed with posi- tron emission tomography[J]. Eur J Nucl Med Mol Imaging, 2011, 38(3); 515-525.
  • 3Bucerius J, Manka C, Schmaljohann J, et al. Feasibitity of [18 F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo [J]. Jacc Cardiovasc Imaging, 2012, 5(5) 528-536.
  • 4Kimes A S, Chefer S I, Matochik J A, et al. Quan- tification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion admin- istration of 2-1-18F] F-A85380[J]. Neuroimage, 2008, 39(2): 717-727.
  • 5Schmaljohann J, Gundisch D, Minnerop M, et al. In vitro evaluation of nicotinic acetylcholine recep tors with 8532-[-18 F]F-A85380 in Parkinson' s dis ease[J]. Nucl Med Biol, 2006, 33(3): a05-a09.
  • 6Baba T, Kikuchi A, Hirayama K, et al. Sever olfactory dysfunc- tion is a prodromal symptom of dementia associated with Parkin- son's disease: a 3 year longitudinal study[J]. Brain, 2012, 135(1): 161-169.
  • 7Weintraub D, Comella CL, Horn S. Parkinson's disease-Part 3: Neuropsychiatric symptoms [J]. Am J Manag Care, 2008, 14(2 Suppl): S59-69.
  • 8Lewis SJG, Slabosz A, Robbins TW, et al. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease[J]. Neuropsychologia, 2005, 43(6): 823-832.
  • 9Hirano S, Shinotoh H, Eidelberg D. Functional brain imaging of cognitive dysfunction in Parkinson's disease [J]. J Neurol Neuro- surg Psychiatry, 2012, 83(10): 963-969.
  • 10Barrett AM, Crucian GP, Schwartz R, et al. Seeing trees but notthe forest: limited perception of large configurations in PD[J]. Neurology, 2001, 56(6): 724-729.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部